ACRX - AcelRx Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts6666
Avg. Estimate-0.2-0.19-0.83-0.74
Low Estimate-0.23-0.24-0.99-1
High Estimate-0.14-0.1-0.55-0.45
Year Ago EPS-0.29-0.28-1.1-0.83
Revenue EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts5566
Avg. Estimate910k2.43M5.5M20.14M
Low EstimateN/AN/AN/A9.1M
High Estimate2.3M8.7M11.5M30.2M
Year Ago Sales2.66M1.49M8M5.5M
Sales Growth (year/est)-65.80%63.40%-31.20%266.20%
Earnings History6/29/20179/29/201712/30/20173/30/2018
EPS Est.-0.28-0.27-0.2-0.24
EPS Actual-0.29-0.28-0.2-0.23
Difference-0.01-0.0100.01
Surprise %-3.60%-3.70%0.00%4.20%
EPS TrendCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.2-0.19-0.83-0.74
7 Days Ago-0.21-0.21-0.89-0.74
30 Days Ago-0.21-0.21-0.89-0.79
60 Days Ago-0.22-0.2-0.93-0.89
90 Days Ago-0.24-0.22-1-0.91
EPS RevisionsCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/A111
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesACRXIndustrySectorS&P 500
Current Qtr.31.00%N/AN/A0.43
Next Qtr.32.10%N/AN/A0.46
Current Year24.50%N/AN/A0.22
Next Year10.80%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A